OLA strategy for ARDS: Its effect on mortality depends on achieved recruitment (PaO2/FiO2) and mechanical power. Systematic review and meta-analysis with meta-regression.

Medicina intensiva
V Modesto I AlapontR Khemani

Abstract

The "Open Lung Approach" (OLA), that includes high levels of positive end-expiratory pressure coupled with limited tidal volumes, is considered optimal for adult patients with ARDS. However, many previous meta-analyses have shown only marginal benefits of OLA on mortality but with statistical heterogeneity. It is crucial to identify the most likely moderators of this effect. To determine the effect of OLA strategy on mortality of ventilated ARDS patients. We hypothesized that the degree of recruitment achieved in the control group (PaO2/FiO2 ratio on day 3 of ventilation), and the difference in Mechanical Power (MP) or Driving Pressure (DP) between experimental and control groups will be the most likely sources of heterogeneity. A Systematic Review and Meta-analysis was performed according to PRISMA statement and registered in PROSPERO database. We searched only for randomized controlled trials (RCTs). GRADE guidelines were used for rating the quality of evidence. Publication bias was assessed. For the Meta-analysis, we used a Random Effects Model. Sources of heterogeneity were explored with Meta-Regression, using a priori proposed set of possible moderators. For model comparison, Akaike's Information Criterion with the finite ...Continue Reading

References

Sep 21, 1996·BMJ : British Medical Journal·S J SharpD G Altman
Feb 5, 1998·The New England Journal of Medicine·M B AmatoC R Carvalho
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
Jul 23, 2004·The New England Journal of Medicine·Roy G BrowerUNKNOWN National Heart, Lung, and Blood Institute ARDS Clinical Trials Network
Feb 14, 2008·JAMA : the Journal of the American Medical Association·Alain MercatUNKNOWN Expiratory Pressure (Express) Study Group
Nov 13, 2008·The New England Journal of Medicine·Daniel TalmorStephen H Loring
Feb 26, 2009·Critical Care : the Official Journal of the Critical Care Forum·Jin Won HuhYounsuck Koh
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Mar 12, 2011·Journal of Applied Physiology·Gaetano PerchiazziGöran Hedenstierna
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Jan 31, 2013·Respiratory Care·María-Consuelo PintadoMiguel Sánchez-García
Feb 19, 2015·The New England Journal of Medicine·Marcelo B P AmatoRoy G Brower
Dec 18, 2015·Critical Care Medicine·Robert M KacmarekUNKNOWN Open Lung Approach Network
Feb 13, 2016·Anesthesiology·Massimo CressoniLuciano Gattinoni
Sep 14, 2016·Intensive Care Medicine·L GattinoniM Quintel
Nov 30, 2016·Critical Care : the Official Journal of the Critical Care Forum·Claude GuérinUNKNOWN investigators of the Acurasys and Proseva trials
Mar 1, 2017·American Journal of Respiratory and Critical Care Medicine·Maureen O MeadeNiall D Ferguson
Oct 4, 2017·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) InvestigatorsCarlos Roberto Ribeiro de Carvalho
Aug 22, 2018·Research Synthesis Methods·Areti Angeliki VeronikiGeorgia Salanti
Jan 13, 2019·BMC Medical Research Methodology·Svenja E SeideTim Friede
May 22, 2019·The New England Journal of Medicine·UNKNOWN National Heart, Lung, and Blood Institute PETAL Clinical Trials NetworkDerek C Angus
Jul 30, 2019·American Journal of Respiratory and Critical Care Medicine·Carol L HodgsonAlistair Nichol

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.